Connect with active cancer research trials at Mary Crowley Cancer Research Centers. This app allows the user to view trials by disease type and molecular target - then email, text or call a live person with questions or to refer a patient. In addition, the user can receive push notifications for any new updates on our trials. This app will streamline the process of connecting and qualifying a patient to an active clinical trial.

Mary Crowley Cancer Research Centers is a 501(c)(3) non-profit cancer research organization founded in 1992 and headquartered in Dallas, Texas. The clinical research center serves advanced cancer patients; those eligible may receive the newest cancer options through Phase 1 and 2 clinical trials in compliance with the U.S. Food and Drug Administration (FDA). The research encompasses all types of metastatic solid cancers in adults as well as Ewing's Sarcoma in children/adolescents with a focus on investigational vaccine, gene, and cellular therapies.

The physician investigators collaborate with community oncologists, major academic centers and biotechnology and pharmaceutical companies across the world to bring the newest discoveries to patients. The scientific basis of Mary Crowley's mission is patient-centric and grounded in the fact that each patient is an individual with a unique molecular blueprint. This personalized approach has been at the forefront of the research conducted at Mary Crowley and includes trials that provide patients with personalized vaccines manufactured specifically for their particular cancer. Mary Crowley Investigators have published hundreds of manuscripts, validating trial results by third party peer-review. Go to www.marycrowley.org for additional information.